VIGIL NEUROSCIENCE INC's ticker is and the CUSIP is 92673K108. A total of 46 filers reported holding VIGIL NEUROSCIENCE INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 1.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,301 | -62.8% | 3,952 | -35.2% | 0.00% | – |
| Q2 2023 | $57,302 | +6705.5% | 6,096 | +6988.4% | 0.00% | – |
| Q1 2023 | $842 | -20.8% | 86 | +1.2% | 0.00% | – |
| Q4 2022 | $1,063 | – | 85 | +57.4% | 0.00% | – |
| Q3 2022 | $0 | – | 54 | +14.9% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 47 | -96.8% | 0.00% | – |
| Q1 2022 | $10,000 | – | 1,465 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Northpond Ventures, LLC | 4,214,498 | $39,616,281 | 65.75% |
| Atlas Venture Life Science Advisors, LLC | 5,836,874 | $54,866,616 | 6.83% |
| Trustees of Columbia University in the City of New York | 192,973 | $1,813,946 | 2.66% |
| Pivotal bioVenture Partners Investment Advisor LLC | 560,595 | $5,269,593 | 1.74% |
| Deep Track Capital, LP | 1,773,409 | $16,670,045 | 0.77% |
| Artal Group S.A. | 1,911,191 | $17,965 | 0.56% |
| BVF INC/IL | 1,813,633 | $17,048,150 | 0.48% |
| DAFNA Capital Management LLC | 172,308 | $1,619,695 | 0.44% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,052,010 | $19,288,894 | 0.41% |
| Cormorant Asset Management, LP | 616,786 | $5,797,788 | 0.32% |